Skip to main content
SpringerLink
Log in
Book cover

Clinical and Basic Immunodermatology pp 771–787Cite as

Immunoglobulin A Dermatoses

  • Chapter

  • 2477 Accesses

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Woof JM, Kerr MA. The function of immunoglobu-lin A in immunity. J Pathol 2006;208(2):270–82.

    Article  PubMed  CAS  Google Scholar 

  2. Wines BD, Hogarth PM. IgA receptors in health and disease. Tissue Antigens 2006;68(2):103–14.

    Article  PubMed  CAS  Google Scholar 

  3. Suda T, Suzuki Y, Matsui T, et al. Dapsone suppresses human neutrophil superoxide production and elastase release in a calcium-dependent manner. Br J Dermatol 2005;152(5):887–95.

    Article  PubMed  CAS  Google Scholar 

  4. Debol SM, Herron MJ, Nelson RD. Anti- inflammatory action of dapsone: inhibition of neutrophil adherence is associated with inhibition of chemoattract-ant-induced signal transduction. J Leukoc Biol 1997;62(6):827–36.

    PubMed  CAS  Google Scholar 

  5. Smith JB, Tulloch JE, Meyer LJ, et al. The incidence and prevalence of dermatitis herpetiformis in Utah. Arch Dermatol 1992;128(12):1608–10.

    Article  PubMed  CAS  Google Scholar 

  6. Spurkland A, Ingvarsson G, Falk ES, et al. Dermatitis herpetiformis and celiac disease are both primarily associated with the HLA-DQ (alpha 1*0501, beta 1*02) or the HLA-DQ (alpha 1*03, beta 1*0302) heterodimers. Tissue Antigens 1997;49(1):29–34.

    Article  PubMed  CAS  Google Scholar 

  7. Fry L, Keir P, McMinn RM, et al. Small-intestinal structure and function and haematological changes in dermatitis herpetiformis. Lancet 1967;2(7519):729–33.

    Article  PubMed  CAS  Google Scholar 

  8. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease.[see comment]. Nature Med 1997;3(7): 797–801.

    Article  PubMed  CAS  Google Scholar 

  9. Sardy M, Karpati S, Merkl B, et al. Epidermal trans-glutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002;195(6):747–57.

    Article  PubMed  CAS  Google Scholar 

  10. Marietta E, Black K, Camilleri M, et al. A new model for dermatitis herpetiformis that uses HLA-DQ8 trans-genic NOD mice. J Clin Invest 2004;114(8):1090–7.

    PubMed  CAS  Google Scholar 

  11. Gaspari AA, Huang CM, Davey RJ, et al. Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA-B8/-DR3. Am J Med 1990;88(2):145–50.

    Article  PubMed  CAS  Google Scholar 

  12. Sigurgeisson B, Agnarsson BA, Lindelof B. Risk of lymphoma in patients with dermatitis herpetiformis. BMJ 1994;308(6920):13–.

    Google Scholar 

  13. Zone JJ, Meyer LJ, Petersen MJ. Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol 1996;132(8):912–8.

    Article  PubMed  CAS  Google Scholar 

  14. Fry L, Walkden V, Wojnarowska F, et al. A comparison of IgA positive and IgA negative dapsone responsive dermatoses. Br J Dermatol 1980;102(4):371–82.

    Article  PubMed  CAS  Google Scholar 

  15. Holtzer CD, Flaherty JF Jr, Coleman RL. Cross-reactivity in HIV-infected patients switched from trimethoprim-sulfamethoxazole to dapsone. Pharmacotherapy 1998;18(4):831–5.

    PubMed  CAS  Google Scholar 

  16. Collier PM, Wojnarowska F, Welsh K, et al. Adult linear IgA disease and chronic bullous disease of childhood: the association with human lymphocyte antigens Cw7, B8, DR3 and tumour necrosis factor influences disease expression. Br J Dermatol 1999;141(5):867–75.

    Article  PubMed  CAS  Google Scholar 

  17. Allen J, Wojnarowska F. Linear IgA disease: the IgA and IgG response to the epidermal antigens demonstrates that intermolecular epitope spreading is associated with IgA rather than IgG antibodies, and is more common in adults. Br J Dermatol 2003;149(5):977–85.

    Article  PubMed  CAS  Google Scholar 

  18. Allen J, Wojnarowska F. Linear IgA disease: the IgA and IgG response to dermal antigens demonstrates a chiefly IgA response to LAD285 and a dermal 180kDa protein. Br J Dermatol 2003;149(5):1055–8.

    Article  PubMed  CAS  Google Scholar 

  19. Peters MS, Rogers RS. Clinical correlations of linear IgA deposition at the cutaneous basement membrane zone. J Am Acad Dermatol 1989;20(5 pt 1):761–70.

    Article  PubMed  CAS  Google Scholar 

  20. Godfrey K, Wojnarowska F, Leonard J. Linear IgA disease of adults: association with lympho-proliferative malignancy and possible role of other triggering factors.[see comment]. Br J Dermatol 1990;123(4):447–52.

    Article  PubMed  CAS  Google Scholar 

  21. Paige DG, Leonard JN, Wojnarowska F, et al. Linear IgA disease and ulcerative colitis. Br J Dermatol 1997;136(5):779–82.

    Article  PubMed  CAS  Google Scholar 

  22. Leonard JN, Haffenden GP, Ring NP, et al. Linear IgA disease in adults. Br J Dermatol 1982;107(3):301–16.

    Article  PubMed  CAS  Google Scholar 

  23. Wojnarowska F, Marsden RA, Bhogal B, et al. Chronic bullous disease of childhood, childhood cic-atricial pemphigoid, and linear IgA disease of adults. A comparative study demonstrating clinical and immunopathologic overlap. J Am Acad Dermatol 1988;19(5 pt 1):792–805.

    PubMed  CAS  Google Scholar 

  24. Yasuda H, Kobayashi H, Hashimoto T, et al. Subcorneal pustular dermatosis type of IgA pemphigus: demonstration of autoantibodies to desmocollin-1 and clinical review. Br J Dermatol 2000;143(1):144–8.

    Article  PubMed  CAS  Google Scholar 

  25. Hashimoto T, Kiyokawa C, Mori O, et al. Human desmocollin 1 (Dsc1) is an autoantigen for the sub-corneal pustular dermatosis type of IgA pemphigus. J Invest Dermatol 1997;109(2):127–31.

    Article  PubMed  CAS  Google Scholar 

  26. Barnadas MA, Perez E, Gich I, et al. Diagnostic, prognostic and pathogenic value of the direct immunofluores-cence test in cutaneous leukocytoclastic vasculitis.[see comment]. Int J Dermatol 2004;43(1):19–26.

    Article  PubMed  Google Scholar 

  27. Magro CM, Crowson AN. A clinical and histologic study of 37 cases of immunoglobulin A-associated vasculitis. Am J Dermatopathol 1999;21(3):234–40.

    Article  PubMed  CAS  Google Scholar 

  28. Tancrede-Bohin E, Ochonisky S, Vignon-Pennamen MD, et al. Schonlein-Henoch purpura in adult patients. Predictive factors for IgA glomerulone-phritis in a retrospective study of 57 cases.[see comment]. Arch Dermatol 1997;133(4):438–42.

    Article  PubMed  CAS  Google Scholar 

  29. Allen DM, Diamond LK, Howell DA. Anaphylactoid purpura in children (Schonlein-Henoch syndrome): review with a follow-up of the renal complications. Am J Dis Child 1960;99:833–54.

    CAS  Google Scholar 

  30. Sterky G, Thilen A. A study on the onset and prognosis of acute vascular purpura (the Schoenlein-Henoch syndrome) in children. Acta Paediatr 1960;49:217–29.

    Article  PubMed  CAS  Google Scholar 

  31. Kauffmann RH, Herrmann WA, Meyer CJ, et al. Circulating IgA-immune complexes in Henoch-Schonlein purpura. A longitudinal study of their relationship to disease activity and vascular deposition of IgA. Am J Med 1980;69(6):859–66.

    Article  PubMed  CAS  Google Scholar 

  32. Levinsky RJ, Barratt TM. IgA immune complexes in Henoch-Schonlein purpura. Lancet 1979;2(8152):1100–3.

    Article  PubMed  CAS  Google Scholar 

  33. Ozaltin F, Bakkaloglu A, Ozen S, et al. The significance of IgA class of antineutrophil cytoplasmic antibodies (ANCA) in childhood Henoch-Schonlein purpura. Clin Rheumatol 2004;23(5):426–9.

    Article  PubMed  Google Scholar 

  34. Saulsbury FT. Alterations in the O-linked glycosyla-tion of IgA1 in children with Henoch-Schonlein purpura. J Rheumatol 1997;24(11):2246–9.

    PubMed  CAS  Google Scholar 

  35. Piette WW, Stone MS. A cutaneous sign of IgA-associated small dermal vessel leukocytoclastic vas-culitis in adults (Henoch-Schonlein purpura). Arch Dermatol 1989;125(1):53–6.

    Article  PubMed  CAS  Google Scholar 

  36. Saulsbury FT. Henoch-Schonlein purpura in children. Report of 100 patients and review of the literature. Medicine 1999;78(6):395–409.

    Article  PubMed  CAS  Google Scholar 

  37. Calvino MC, Llorca J, Garcia-Porrua C, et al. Henoch-Schonlein purpura in children from northwestern Spain: a 20—year epidemiologic and clinical study. Medicine 2001;80(5):279–90.

    Article  PubMed  CAS  Google Scholar 

  38. Narchi H. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schonlein purpura with normal or minimal urinary findings: a systematic review. Arch Dis Child 2005;90(9):916–20.

    Article  PubMed  CAS  Google Scholar 

  39. Pillebout E, Thervet E, Hill G, et al. Henoch-Schonlein Purpura in Adults: Outcome and Prognostic Factors. J Am Soc Nephrol 2002;13(5):1271–8.

    Article  PubMed  Google Scholar 

  40. Niaudet P, Habib R. Methylprednisolone pulse therapy in the treatment of severe forms of Schonlein-Henoch purpura nephritis. Pediatr Nephrol 1998; 12(3):238–43.

    Article  PubMed  CAS  Google Scholar 

  41. Foster BJ, Bernard C, Drummond KN, et al. Effective therapy for severe Henoch-Schonlein purpura nephritis with prednisone and azathio-prine: a clinical and histopathologic study. J Pediatr 2000;136(3):370–5.

    Article  PubMed  CAS  Google Scholar 

  42. Iqbal H, Evans A. Dapsone therapy for Henoch-Schonlein purpura: a case series. Arch Dis Child 2005;90(9):985–a-6.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Emory University School of Medicine, Atlanta, GA, USA

    Todd V. Cartee & Robert A. Swerlick

Authors
  1. Todd V. Cartee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Robert A. Swerlick
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Dermatology, University of Maryland School of Medicine, Baltimore, MD, USA

    Anthony A. Gaspari MD

  2. Department of Dermatology, University of Texas Medical School at Houston, Houston, TX, USA

    Stephen K. Tyring MD, PhD

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer-Verlag London Limited

About this chapter

Cite this chapter

Cartee, T.V., Swerlick, R.A. (2008). Immunoglobulin A Dermatoses. In: Gaspari, A.A., Tyring, S.K. (eds) Clinical and Basic Immunodermatology. Springer, London. https://doi.org/10.1007/978-1-84800-165-7_45

Download citation

  • DOI: https://doi.org/10.1007/978-1-84800-165-7_45

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-84800-164-0

  • Online ISBN: 978-1-84800-165-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation